Rare Disease Community App Market Report 2025

The rare disease community app market size has grown rapidly in recent years. It will grow from $0.81 billion in 2024 to $0.92 billion in 2025 at a compound annual growth rate (CAGR) of 13.7%. The growth in the historic period can be attributed to increasing patient engagement through online communities, rising reliance on mobile applications for health tracking, growing availability of educational resources for rare diseases, heightened emphasis on collecting patient-reported outcomes, and increased trust in secure data-sharing platforms.

The rare disease community app market size is expected to see rapid growth in the next few years. It will grow to $1.52 billion in 2029 at a compound annual growth rate (CAGR) of 13.3%. The growth in the forecast period can be attributed to the rising integration of wearable devices with community apps, growing adoption of blockchain for secure patient data management, increasing demand for multi-language support within apps, expansion of virtual clinical trial recruitment through app platforms, and the rise of gamification features to enhance patient engagement. Major trends in the forecast period include integration of artificial intelligence-driven chatbots, blockchain-enabled data security systems, cloud-native microservices architecture, interoperability with electronic health records (EHRs), and incorporation of genomic data analytics for personalized patient insights.

The growing adoption of digital health solutions is expected to drive the growth of the rare disease community app market. Digital health solutions involve using technology, software, and digital tools to enhance healthcare delivery, management, and patient outcomes. This surge in adoption is largely due to the improved patient monitoring capabilities of these solutions, which enable real-time tracking of health data and more personalized care management. Digital health platforms are accelerating the use of rare disease community apps by providing seamless access to virtual care, real-time health insights, and personalized tools, which significantly enhance their value for users. For example, a 2022 Digital Health Consumer Adoption Survey by Rock Health found that 80% of respondents had used telemedicine at least once during 2022, a notable increase from 72% in 2021. This trend is contributing to the growth of the rare disease community app market.

Key companies in the rare disease community app market are integrating advanced technologies such as natural language processing (NLP) analytics. NLP uses artificial intelligence algorithms to understand, interpret, and summarize human language data, providing actionable insights for healthcare management. For example, in December 2024, Know Rare, Inc., a UK-based health tech firm, launched the HealthStoryAI app to help individuals with rare diseases. The app allows users to record and monitor their daily health experiences, offering a structured way to track symptoms and health patterns. By leveraging AI, it automatically summarizes patient-reported experiences and highlights health trends over time. HealthStoryAI also provides personalized insights, aiding both patients and healthcare providers in identifying patterns and making better-informed care decisions. The app helps empower the rare disease community with tools for better self-management and optimized healthcare.

In October 2023, PicnicHealth, a U.S.-based health technology company, acquired AllStripes for an undisclosed amount to expand its rare disease data capabilities. This acquisition will strengthen PicnicHealth's patient-centered research and help accelerate the generation of real-world evidence, which is crucial for drug development and regulatory approvals. AllStripes specializes in rare disease data collection and the generation of real-world evidence, complementing PicnicHealth’s focus on enhancing healthcare outcomes for rare disease patients.

Major players in the rare disease community app market are Novartis AG, Takeda Pharmaceutical Company Limited, The Mighty Networks Inc., PicnicHealth Inc., Medisafe Inc., FDNA Inc., RareConnect, Carenity SAS, MyHealthTeam Inc., CureDuchenne Inc., Aparito Limited, Healp Inc., ThinkGenetic Inc., Know Rare Inc., OpenApp Limited, Rare Patient Voice LLC, Inspire Inc., Mejo Inc., RareGuru LLC, and Xperiome Ltd.

North America was the largest region in the rare disease community app market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in rare disease community app report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the rare disease community app market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

A rare disease community app is a digital platform designed to connect patients, caregivers, and healthcare professionals affected by rare diseases. It provides resources, support networks, and condition-specific information to foster knowledge sharing, emotional support, and active engagement within the rare disease community. The app helps users navigate complex healthcare journeys more effectively and stay informed about disease management, clinical trials, and emerging therapies.

The primary platforms of the rare disease community app include iOS, Android, and web-based applications. iOS refers to apps developed for Apple devices, enabling patients and caregivers to access disease-related resources and community features seamlessly. Deployment modes include cloud-based and on-premises solutions. The application types include patient support, disease management, clinical trial recruitment, information sharing, and others. Key end-users include patients, caregivers, healthcare professionals, researchers, and other stakeholders in rare disease care and advocacy.

The rare disease community app market research report is one of a series of new reports that provides rare disease community app market statistics, including the rare disease community app industry global market size, regional shares, competitors with the rare disease community app market share, detailed rare disease community app market segments, market trends, and opportunities, and any further data you may need to thrive in the rare disease community app industry. This rare disease community app market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The rare disease community app market consists of revenues earned by entities by providing services such as health tracking and symptom monitoring, information and education, and community connection and support. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.